AlphaFold predicted structure
HCFC1 · P51610

Mean pLDDT
46.4/ 100
Very low
2,035 residues
Confidence breakdown
- Very high(≥ 90)19%
- Confident(70–90)7%
- Low(50–70)2%
- Very low(< 50)73%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
host cell factor C1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesDDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesEarly onset or syndromic epilepsy
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesIntellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesLikely inborn error of metabolism
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesUndiagnosed metabolic disorders
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFamilial Meniere Disease
methylmalonic acidemia with homocystinuria, type cblX
hereditary disease
X-linked intellectual disability
Intellectual disability
X-linked non-syndromic intellectual disability
non-syndromic X-linked intellectual disability
Methylmalonic acidemia with homocystinuria
methylmalonic aciduria and homocystinuria type cblC
Methylmalonic acidemia with homocystinuria, type cblC
rheumatoid arthritis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Host cell factor 1
Transcriptional coregulator (By similarity). Serves as a scaffold protein, bridging interactions between transcription factors, including THAP11 and ZNF143, and transcriptional coregulators (PubMed:26416877). Involved in control of the cell cycle (PubMed:10629049, PubMed:10779346, PubMed:15190068, PubMed:16624878, PubMed:23629655). Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 (PubMed:10675337, PubMed:12244100). Coactivator for EGR2 and GABP2 (PubMed:12244100, PubMed:14532282). Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription, respectively) together (PubMed:12670868). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 (PubMed:20200153). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition (PubMed:23629655). Modulates expression of homeobox protein PDX1, perhaps acting in concert with transcription factor E2F1, thereby regulating pancreatic beta-cell growth and glucose-stimulated insulin secretion (By similarity). May negatively modulate transcriptional activity of FOXO3 (By similarity)
HCFC1 · P51610

Mean pLDDT
46.4/ 100
Very low
2,035 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0